glp-1 drugs and breast cancer The Impact Safety of GLP‐1 Agents and GLP-1 Drugs May Improve Survival
Description
Muscle Mass Reduction Studies indicate that up to 40% of weight loss on some GLP-1 medications can actually be lean muscle rather than fat tissue
Zepbound, KwikPen, and LillyDirect are registered trademarks, and Foundayo is a trademark of Eli Lilly and Company
these patients may benefit from an emphasis on glycemic control
Phase 2 data does not capture long-term safety
Based on animal studies, there may be potential risks to an unborn baby from exposure to Wegovy during pregnancy
Thirdly, residual confounding is a possibility owing to the observational nature of the study
